Gaurav Shah Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity
Gaurav Shah is CEO of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 718,419 shares of RCKT, which is worth approximately $11.8 Million. The most recent transaction as insider was on Aug 16, 2024, when has been sold 9,650 shares (Common Stock) at a price of $18.5 per share, resulting in proceeds of $178,525. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
718K
1.33%
3M change
36.88%
12M change
Total Value Held
$11.8 Million
Gaurav Shah Transaction History
Also insider at
GS
Gaurav Shah
CEO
Cranbury, NJ